A brain glioblastoma is a primary brain tumor involving glial cells. It is aggressive, malignant, and common; comprising 52% of all brain tumor cases. The tumors arise from astrocytes, or cells that exist in the supportive tissue of the brain. The exact cause of this tumor is not known. The large amount of blood flow that continuously goes throughout the brain facilitates the rapid growth of this tumor. There are primary and secondary forms of brain glioblastoma, with the primary following a very rapid progression and the secondary beginning as lower grade tumors and eventually becoming higher grade. The most common symptoms occur due to an increased pressure on the brain, and include headaches, nausea, and drowsiness. The standard treatment is surgery to remove the tumor, but the aggressive nature of the glioblastoma frequently makes that impossible. The median survival time with treatment is 15 months, and the five-year survival rate is around 4%. An important gene associated with this brain glioblastoma is the TNSF13 gene.
Brain Glioblastoma Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Brain Glioblastoma below!
For more information on how to use Laverne, please read the How to Guide.
We have 1172 products for the study of Brain Glioblastoma that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence from our catalog of antibodies and ELISA kits.